Literature DB >> 12867576

T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion.

D O'Gradaigh1, J E Compston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12867576     DOI： 10.1093/rheumatology/keg447

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Spontaneous and induced osteoclastogenic behaviour of human peripheral blood mononuclear cells and their CD14(+) and CD14(-) cell fractions.

Authors:  J Costa-Rodrigues; A Fernandes; M H Fernandes
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

Review 3.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

4.  Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis.

Authors:  Eun Young Lee; Miran Seo; Yong-Sung Juhnn; Jeong Yeon Kim; Yoo Jin Hong; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Arthritis Res Ther       Date:  2011-06-27       Impact factor: 5.156

5.  T cells as key players for bone destruction in gouty arthritis?

Authors:  Ulrike Harre; Anja Derer; Christine Schorn; Georg Schett; Martin Herrmann
Journal:  Arthritis Res Ther       Date:  2011-12-02       Impact factor: 5.156

Review 6.  Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.

Authors:  Kehmia Titanji
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

7.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

Review 8.  Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.

Authors:  Rainer Zenz; Robert Eferl; Clemens Scheinecker; Kurt Redlich; Josef Smolen; Helia B Schonthaler; Lukas Kenner; Erwin Tschachler; Erwin F Wagner
Journal:  Arthritis Res Ther       Date:  2008-01-18       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.